{"id":227894,"date":"2017-07-15T06:46:47","date_gmt":"2017-07-15T10:46:47","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/gene-therapy-one-step-closer-to-fda-approval-video-njtv-news-njtv-news.php"},"modified":"2017-07-15T06:46:47","modified_gmt":"2017-07-15T10:46:47","slug":"gene-therapy-one-step-closer-to-fda-approval-video-njtv-news-njtv-news","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/gene-therapy-one-step-closer-to-fda-approval-video-njtv-news-njtv-news.php","title":{"rendered":"Gene therapy one step closer to FDA approval | Video | NJTV News &#8211; NJTV News"},"content":{"rendered":"<p><p>    By Briana    Vannozzi    Correspondent  <\/p>\n<p>    Looking at 17 year-old camp counselor Justin Pritikin, youd    never imagine he just battled a leukemia relapse.  <\/p>\n<p>    When I first got diagnosed, you know, they say you cant    really understand or whatever. I got the gist of it    immediately. I was like, OK he said.  <\/p>\n<p>    Not only did he get the gist, Justin was determined to beat it    and a new gene therapy has become his best weapon. Scientists    are reporting unprecedented success with a new T-cell    treatment, using the patients own immune system to fight the    cancer.  <\/p>\n<p>    This is a therapy that uses the patients own cells that have    been genetically engineered, and when infused back into the    patient will locate the tumor cells and kill those tumor cells.    Thats never, we have nothing like that in the arsenal today,    said Dr. Lee Greenberger, chief scientific officer of the    Leukemia & Lymphoma    Society.  <\/p>\n<p>    Just this week an FDA panel    unanimously recommended approval of whats being dubbed the    second chance cancer treatment because it works best on    patients whos first line of drugs  traditional chemo and    radiation  failed.  <\/p>\n<p>    He was originally diagnosed with acute lymphoblastic leukemia    back in March 2012 and he was doing great, said mother Jill    Pritikin. He had standard therapy, which is chemotherapy. For    boys, three and a half years is your road map of treatment. And    he was off chemo for about a year and four months and then he    relapsed just in November 2016 with the exact same cancer.  <\/p>\n<p>    It was horrible watching him go through the regular stuff, the    regular chemo. To watch him go through this new T-cell    treatment, its sort of like youre part of a magic trick. Like    you really cant believe what they do, said father Andy    Pritikin.  <\/p>\n<p>    After the white blood, or T-cells are removed from the patient,    the new CAR T-cells are put back where they divide and conquer.  <\/p>\n<p>    We weighed our options. We looked at bone marrow transplant,    it wasnt a good option at the time. We looked at doing another    round of intense chemo, but with my type of cancer it was    probably going to come back, so that wasnt a great option. We    looked at a different study, but it wasnt as promising as this    one, Justin said.  <\/p>\n<p>    I can tell you seeing this firsthand, seeing the difference    that it makes, seeing all these kids in treatment at hospitals,    its very moving, Andy said.  <\/p>\n<p>    After five years missing school and friends, it took just one    T-cell treatment to get him back on his feet, in remission, at    the Burlington County summer camp run by his parents.  <\/p>\n<p>    I mean, Im at camp. I got diagnosed in November. Im working    long days and hot hours with many kids who are loud or whatever    and I feel fine with it. So it must have worked, I think,    Justin said.  <\/p>\n<p>    Though scientists warn there can be severe side effects  some    nearly fatal  serious infections can occur or a syndrome that    resembles sepsis. Fortunately for Justin he had none. Still the    benefits, seem to outweigh the cons.  <\/p>\n<p>    It can produce dramatic effects to kill tumor cells that are    long lasting  years. In fact as best as we know, maybe    indefinitely. It looks like, in some patients, like a cure with    a single dose of this new therapy cure. Thats truly    remarkable, said Greenberger.  <\/p>\n<p>    Hes back to being a 17-year-old full of energy, making me    crazy because hes doing regular 17-year-old things. You know,    staying out late with friends. Its good. Im optimistic, but    Im realistic at the same time. So you know, youre never going    to shake that feeling that this might not be over, but you    know, for now were living in the moment. I mean thats all    anybody has, so thats kind of how we have to approach life,    said Jill.  <\/p>\n<p>    The FDA could approve the therapy as early as this year.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Link: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.njtvonline.org\/news\/video\/gene-therapy-one-step-closer-fda-approval\/\" title=\"Gene therapy one step closer to FDA approval | Video | NJTV News - NJTV News\">Gene therapy one step closer to FDA approval | Video | NJTV News - NJTV News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> By Briana Vannozzi Correspondent Looking at 17 year-old camp counselor Justin Pritikin, youd never imagine he just battled a leukemia relapse. When I first got diagnosed, you know, they say you cant really understand or whatever.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/gene-therapy-one-step-closer-to-fda-approval-video-njtv-news-njtv-news.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-227894","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/227894"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=227894"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/227894\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=227894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=227894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=227894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}